import type { Metadata } from 'next'
import Link from 'next/link'
import Image from 'next/image'
import { buildPageMetadata } from '../../../../src/lib/seo'
import AuthorityJsonLd from '@/components/seo/AuthorityJsonLd'
import AuthorityBreadcrumbs from '@/components/navigation/AuthorityBreadcrumbs'
import LegacyGuideFAQ from '@/components/LegacyGuideFAQ'
import LegacyGuideQuickAnswer from '@/components/LegacyGuideQuickAnswer'
import References from '@/components/References'
import EmailCapture from '../../../../components/EmailCapture'
import RecommendationSection from '@/components/RecommendationSection'
import { getRevenueProductSet } from '@/config/revenue-products'

export const metadata: Metadata = buildPageMetadata({
  title: 'Anti-Inflammatory Supplements: Evidence Review (2026)',
  description:
    'Outcome-specific 2026 review of curcumin, omega-3, ginger, Boswellia, and quercetin—what human evidence supports, what remains uncertain, and where safety or formulation changes the answer.',
  path: '/guides/other/anti-inflammatory-supplements/',
  openGraphType: 'article',
})

const FAQS = [
  {
    question: 'What is the best natural anti-inflammatory supplement?',
    answer:
      'There is no evidence-based universal winner. Curcumin and Boswellia have human evidence for some knee-osteoarthritis symptoms, omega-3 fatty acids have anti-inflammatory biology plus selected rheumatoid-arthritis and cardiovascular evidence, and ginger has human evidence for primary dysmenorrhea. Those are different outcomes, populations, products, and evidence bases—not one ranking.',
  },
  {
    question: 'Can turmeric or curcumin replace ibuprofen or another NSAID?',
    answer:
      'Do not treat turmeric or curcumin as a drop-in replacement for an NSAID. Some osteoarthritis trials and syntheses report symptom improvement, but formulation and study quality vary and NCCIH says the evidence is not definitive. Do not stop or replace prescribed or over-the-counter medicines without discussing the reason, risks, and alternatives with a clinician or pharmacist.',
  },
  {
    question: 'How much omega-3 should someone take for inflammation?',
    answer:
      'There is no universal EPA+DHA dose validated for a generic diagnosis of “inflammation.” Dose and formulation depend on the studied outcome. High-dose prescription omega-3 therapy for severe hypertriglyceridemia is a different clinical use from taking a retail fish-oil supplement, and high-dose trials have identified risks that matter in selected patients.',
  },
  {
    question: 'What causes chronic inflammation?',
    answer:
      'Inflammation is a biological process, not one diagnosis. Persistent inflammatory activity can accompany infections, autoimmune disease, obesity, smoking, sleep disruption, periodontal disease, inflammatory disorders, and many other conditions. A supplement should not substitute for identifying and treating the underlying cause when symptoms or abnormal inflammatory markers are persistent.',
  },
  {
    question: 'Should curcumin, omega-3, ginger, and Boswellia be stacked together?',
    answer:
      'There is not a robust clinical evidence base showing that a four-supplement stack produces better patient-important outcomes than using an appropriately chosen intervention for a specific indication. Combining supplements can also change tolerability and interaction risk. Use the evidence for the actual condition and review combinations with a clinician or pharmacist when medications, pregnancy, bleeding risk, liver disease, or other medical issues are relevant.',
  },
] as const

const ANTI_INFLAM_REFS = [
  {
    n: 1,
    text: 'Inprasit C, et al. Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: a systematic review and network meta-analysis. Complement Ther Med. 2026;96:103256. PMID 41082950.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/41082950/',
    pmid: '41082950',
  },
  {
    n: 2,
    text: 'Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105-1115. PMID 28900017.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/28900017/',
    pmid: '28900017',
  },
  {
    n: 3,
    text: 'Moshfeghinia R, et al. Ginger for Pain Management in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. J Integr Complement Med. 2024;30(11):1016-1030. PMID 38770631.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/38770631/',
    pmid: '38770631',
  },
  {
    n: 4,
    text: 'Dalmonte T, et al. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Phytother Res. 2024;38(12):5672-5689. PMID 39314013.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/39314013/',
    pmid: '39314013',
  },
  {
    n: 5,
    text: 'Li Y, et al. Quercetin, Inflammation and Immunity. Nutrients. 2016;8(3):167. PMID 26999194.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/26999194/',
    pmid: '26999194',
  },
  {
    n: 6,
    text: 'National Center for Complementary and Integrative Health. Turmeric: Usefulness and Safety. Current evidence and safety summary, including formulation variability and reported liver injury with some highly bioavailable products.',
    url: 'https://www.nccih.nih.gov/health/turmeric',
  },
  {
    n: 7,
    text: 'NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Health Professional Fact Sheet. Current efficacy, safety, and interaction summary.',
    url: 'https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/',
  },
  {
    n: 8,
    text: 'Daily JW, et al. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016;19(8):717-729. PMID 27533649.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/27533649/',
    pmid: '27533649',
  },
]

export default function AntiInflammatoryPage() {
  return (
    <div className="container-page py-10 space-y-10">
      <AuthorityJsonLd
        title="Anti-Inflammatory Supplements: Outcome-Specific Evidence Review"
        description="Evidence-calibrated comparison of curcumin, omega-3, ginger, Boswellia, and quercetin by studied outcome, formulation, and safety limitations."
        url="https://thehippiescientist.net/guides/other/anti-inflammatory-supplements/"
        type="MedicalWebPage"
        citationUrls={ANTI_INFLAM_REFS.map(reference => reference.url)}
      />
      <AuthorityBreadcrumbs items={[{ label: 'Home', href: '/' }, { label: 'Guides', href: '/guides/' }, { label: 'Anti-Inflammatory Supplements' }]} />

      <section className="space-y-5 max-w-4xl">
        <p className="eyebrow-label">Evidence Review · 8 References · Updated August 16, 2026</p>
        <h1 className="text-5xl font-bold tracking-tight text-ink">Anti-Inflammatory Supplements: What the Evidence Actually Supports</h1>
        <p className="text-lg leading-8 text-muted">
          “Anti-inflammatory” is too broad to rank supplements responsibly. A product can alter an inflammatory pathway or biomarker without improving pain, function, cardiovascular outcomes, or a specific inflammatory disease. This review therefore separates the evidence by <strong>outcome, population, formulation, and study type</strong> rather than declaring one universal best supplement.
        </p>
        <figure className="mt-6">
          <div className="overflow-hidden rounded-2xl border border-brand-900/10 shadow-sm bg-white">
            <Image src="/images/guides/anti-inflammatory-supplements.jpg" alt="Turmeric root, omega-3 capsules, and ginger used in anti-inflammatory supplement research" width={1536} height={1024} priority className="w-full h-auto" />
          </div>
          <figcaption className="mt-3 text-center text-sm text-muted">The useful question is not “which supplement lowers inflammation?” but “which intervention improved which outcome in which population?”</figcaption>
        </figure>
      </section>

      <LegacyGuideQuickAnswer referencesHref="#references">
        <p>
          The most defensible human evidence in this group is <strong>outcome-specific</strong>. Curcumin/turmeric and Boswellia have signals for knee-osteoarthritis symptoms, but results vary by formulation and synthesis [1,4,8]. Omega-3 EPA/DHA has established anti-inflammatory biology and selected clinical evidence, but effects differ by condition and high-dose prescription uses should not be collapsed into a generic supplement recommendation [2,7]. Ginger has a human pain signal for primary dysmenorrhea, with substantial heterogeneity and incomplete safety reporting [3]. Quercetin has interesting inflammatory biology, but the cited literature is much more mechanistic than proof of a specific clinical anti-inflammatory treatment [5].
        </p>
        <p className="mt-3">
          None of these evidence bases supports a universal “anti-inflammatory stack,” a single consumer dose for “inflammation,” or replacing diagnosis and established treatment of an inflammatory condition with supplements.
        </p>
      </LegacyGuideQuickAnswer>

      <section id="anti-inflammatory-evidence-ledger" data-answer-engine-table="true" className="card-premium scroll-mt-24 p-6 space-y-4 max-w-5xl border-l-4 border-brand-700 bg-brand-50/30">
        <p className="eyebrow-label">Outcome-specific evidence ledger</p>
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Five ingredients, five different evidence questions</h2>
        <div className="overflow-x-auto">
          <table className="min-w-[940px] w-full text-sm">
            <caption className="sr-only">Clinical evidence and limitations for common supplements marketed as anti-inflammatory</caption>
            <thead>
              <tr className="border-b border-brand-900/10">
                <th scope="col" className="text-left py-2 pr-4 font-semibold text-ink">Ingredient</th>
                <th scope="col" className="text-left py-2 pr-4 font-semibold text-ink">Best-supported question here</th>
                <th scope="col" className="text-left py-2 pr-4 font-semibold text-ink">What the evidence says</th>
                <th scope="col" className="text-left py-2 font-semibold text-ink">Main limitation</th>
              </tr>
            </thead>
            <tbody className="text-muted">
              <tr className="border-b border-brand-900/5 align-top">
                <th scope="row" className="py-3 pr-4 text-left font-medium text-ink">Curcumin / turmeric</th>
                <td className="py-3 pr-4">Knee-OA pain and function</td>
                <td className="py-3 pr-4">Several syntheses report symptom signals, including formulation-specific effects [1,8]</td>
                <td className="py-3">Products and bioavailability strategies differ; NCCIH says evidence is not definitive and reports liver injury with some highly bioavailable formulations [6]</td>
              </tr>
              <tr className="border-b border-brand-900/5 align-top">
                <th scope="row" className="py-3 pr-4 text-left font-medium text-ink">Omega-3 EPA/DHA</th>
                <td className="py-3 pr-4">Inflammatory pathways and selected disease-specific outcomes</td>
                <td className="py-3 pr-4">Human evidence includes rheumatoid-arthritis and cardiometabolic contexts, but results are condition-specific [2,7]</td>
                <td className="py-3">Retail supplements, diet, and prescription high-dose omega-3 are not interchangeable evidence categories; 4-g/day trials have shown a small atrial-fibrillation signal in high-risk populations [7]</td>
              </tr>
              <tr className="border-b border-brand-900/5 align-top">
                <th scope="row" className="py-3 pr-4 text-left font-medium text-ink">Ginger</th>
                <td className="py-3 pr-4">Primary dysmenorrhea pain</td>
                <td className="py-3 pr-4">A 2024 meta-analysis found lower pain intensity and duration versus placebo [3]</td>
                <td className="py-3">High heterogeneity; safety reporting was incomplete; this does not establish ginger as a universal anti-inflammatory or muscle-recovery treatment [3]</td>
              </tr>
              <tr className="border-b border-brand-900/5 align-top">
                <th scope="row" className="py-3 pr-4 text-left font-medium text-ink">Boswellia</th>
                <td className="py-3 pr-4">Knee-OA symptoms</td>
                <td className="py-3 pr-4">Some formulations and analyses report symptom improvement [1]</td>
                <td className="py-3">A separate 2024 meta-analysis found no significant pooled WOMAC/VAS effect because of high heterogeneity, so a category-wide grade would hide real disagreement [4]</td>
              </tr>
              <tr className="align-top">
                <th scope="row" className="py-3 pr-4 text-left font-medium text-ink">Quercetin</th>
                <td className="py-3 pr-4">Inflammatory mechanisms and immune biology</td>
                <td className="py-3 pr-4">Mechanistic and preclinical literature is substantial [5]</td>
                <td className="py-3">That is not the same as robust evidence for treating allergy, mast-cell disease, arthritis, or a generic state of “inflammation” in humans</td>
              </tr>
            </tbody>
          </table>
        </div>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <p className="eyebrow-label">Why the old stack model fails</p>
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Mechanisms do not make ingredients automatically additive</h2>
        <p className="text-sm leading-7 text-muted">
          Two supplements can act on different inflammatory pathways without a trial showing that the combination improves a patient-important outcome. The previous version of this guide converted pathway diversity into a default curcumin-plus-omega-3 stack and then suggested adding ginger or Boswellia. The cited evidence does not establish that sequence as a validated treatment strategy.
        </p>
        <p className="text-sm leading-7 text-muted">
          A better approach is to start with the <strong>actual clinical problem</strong>: for example, knee-OA symptoms, severe hypertriglyceridemia, primary dysmenorrhea, rheumatoid arthritis, or an unexplained elevated inflammatory marker. Those are different questions and can require very different evaluation and treatment.
        </p>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <p className="eyebrow-label">Safety and formulation boundaries</p>
        <h2 className="text-2xl font-semibold tracking-tight text-ink">“Natural” does not remove dose, interaction, or product-quality questions</h2>
        <ul className="list-disc space-y-2 pl-5 text-sm leading-7 text-muted">
          <li><strong>Curcumin:</strong> NCCIH notes substantial formulation variability and reports liver injury in some users of highly bioavailable formulations [6]. That makes “more absorption is always better” an unsafe shortcut.</li>
          <li><strong>Omega-3:</strong> NIH ODS separates food intake, supplements, and prescription products and notes medication interactions plus a small atrial-fibrillation signal in some long-term 4-g/day trials [7].</li>
          <li><strong>Ginger:</strong> a condition-specific efficacy signal does not substitute for a complete safety database; the 2024 dysmenorrhea synthesis noted infrequent safety reporting [3].</li>
          <li><strong>Boswellia:</strong> extract composition matters. Results from one standardized formulation should not be generalized automatically to every retail resin extract [1,4].</li>
          <li><strong>Quercetin:</strong> strong mechanism language is not a clinical indication. Medication use, pregnancy, kidney/liver disease, or other medical conditions can change whether supplement use deserves professional review.</li>
        </ul>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <p className="eyebrow-label">Evidence applicability</p>
        <h2 className="text-2xl font-semibold tracking-tight text-ink">What this page does not claim</h2>
        <ul className="list-disc space-y-2 pl-5 text-sm leading-7 text-muted">
          <li>It does not claim that lowering CRP or changing an inflammatory pathway automatically improves symptoms or prevents disease.</li>
          <li>It does not rank a supplement as “best” across osteoarthritis, autoimmune disease, cardiovascular disease, exercise soreness, and menstrual pain.</li>
          <li>It does not convert study doses into a personalized protocol.</li>
          <li>It does not assume that curcumin, omega-3, ginger, Boswellia, and quercetin are safer than NSAIDs or prescription treatment as a class.</li>
          <li>It does not treat one branded or bioavailability-enhanced formulation as evidence for all products with the same ingredient name.</li>
        </ul>
      </section>

      <section className="card-premium p-6 space-y-4 max-w-4xl">
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Bottom line</h2>
        <p className="text-sm leading-7 text-muted">
          Several supplements marketed as anti-inflammatory have legitimate human research, but the evidence is <strong>condition-specific and formulation-sensitive</strong>. Curcumin and Boswellia have the clearest discussion here in knee osteoarthritis, ginger has a signal in dysmenorrhea, omega-3 evidence varies by disease and product type, and quercetin remains much stronger mechanistically than clinically. The useful edge is not a five-product stack—it is matching a claim to the outcome that was actually studied and preserving the uncertainty around safety, formulation, and generalizability [1-8].
        </p>
      </section>

      <LegacyGuideFAQ questions={[...FAQS]} pagePath="/guides/other/anti-inflammatory-supplements/" />

      <section className="card-premium p-6 space-y-3 max-w-4xl">
        <h2 className="text-2xl font-semibold tracking-tight text-ink">Related reading</h2>
        <p className="text-sm leading-7 text-muted">Go deeper on the ingredients and outcome-specific evidence:</p>
        <ul className="grid gap-2 sm:grid-cols-2 text-sm font-semibold text-brand-800">
          <li><Link href="/guides/other/curcumin-absorption-guide/" className="hover:underline">Curcumin absorption guide →</Link></li>
          <li><Link href="/guides/other/omega-3-quality-guide/" className="hover:underline">Omega-3 quality guide →</Link></li>
          <li><Link href="/herbs/turmeric/" className="hover:underline">Turmeric herb profile →</Link></li>
          <li><Link href="/herbs/ginger/" className="hover:underline">Ginger herb profile →</Link></li>
          <li><Link href="/compounds/omega-3-epa/" className="hover:underline">Omega-3 (EPA) compound profile →</Link></li>
          <li><Link href="/guides/best/supplements-for-joint-support/" className="hover:underline">Supplements for joint support →</Link></li>
        </ul>
      </section>

      <div className="max-w-4xl rounded-xl border border-brand-900/10 bg-brand-50/40 p-4 text-xs leading-6 text-muted">
        <strong className="text-ink">Commercial-links boundary:</strong> optional product links are sourcing examples, not evidence that a retail formulation reproduces the products, doses, bioavailability, safety, or clinical effects in the cited studies.
      </div>
      <div className="max-w-4xl">
        <RecommendationSection
          title="Curcumin product examples"
          description="If you are comparing retail curcumin products, formulation and ingredient identity matter. These links are optional sourcing examples—not a recommendation to treat an inflammatory condition, combine products into a stack, or prefer maximal bioavailability."
          products={getRevenueProductSet('turmeric')?.products ?? []}
        />
      </div>

      <References refs={ANTI_INFLAM_REFS} />
      <EmailCapture headline="Get evidence reviews like this" description="Anti-inflammatory, omega-3, curcumin — evidence, not hype." ctaLabel="Get the evidence" location="guide-anti-inflammatory" />
      <div className="pt-4 border-t border-brand-900/10 flex items-center justify-between"><Link href="/guides/" className="inline-flex rounded-full border border-brand-900/10 bg-[var(--surface-card)] px-4 py-2 text-sm font-bold text-ink transition hover:bg-brand-50">← Back to guides</Link><Link href="/herbs/" className="text-sm font-bold text-brand-800 hover:underline">Herb library →</Link></div>
    </div>
  )
}
